JP2012503987A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012503987A5 JP2012503987A5 JP2011529292A JP2011529292A JP2012503987A5 JP 2012503987 A5 JP2012503987 A5 JP 2012503987A5 JP 2011529292 A JP2011529292 A JP 2011529292A JP 2011529292 A JP2011529292 A JP 2011529292A JP 2012503987 A5 JP2012503987 A5 JP 2012503987A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence
- retrovirus
- polynucleotide
- retroviral
- domain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10066608P | 2008-09-26 | 2008-09-26 | |
| US61/100,666 | 2008-09-26 | ||
| US12061808P | 2008-12-08 | 2008-12-08 | |
| US61/120,618 | 2008-12-08 | ||
| US18682309P | 2009-06-13 | 2009-06-13 | |
| US61/186,823 | 2009-06-13 | ||
| PCT/US2009/058512 WO2010036986A2 (en) | 2008-09-26 | 2009-09-26 | Recombinant vectors |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015004923A Division JP5992548B2 (ja) | 2008-09-26 | 2015-01-14 | 組換えベクター |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012503987A JP2012503987A (ja) | 2012-02-16 |
| JP2012503987A5 true JP2012503987A5 (enExample) | 2012-11-15 |
| JP5684130B2 JP5684130B2 (ja) | 2015-03-11 |
Family
ID=42060421
Family Applications (6)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011529291A Expired - Fee Related JP5771147B2 (ja) | 2008-09-26 | 2009-09-26 | 遺伝子治療ベクターおよびシトシンデアミナーゼ |
| JP2011529292A Expired - Fee Related JP5684130B2 (ja) | 2008-09-26 | 2009-09-26 | 組換えベクター |
| JP2015004923A Expired - Fee Related JP5992548B2 (ja) | 2008-09-26 | 2015-01-14 | 組換えベクター |
| JP2015097980A Expired - Fee Related JP6062485B2 (ja) | 2008-09-26 | 2015-05-13 | 遺伝子治療ベクターおよびシトシンデアミナーゼ |
| JP2016159893A Expired - Fee Related JP6523224B2 (ja) | 2008-09-26 | 2016-08-17 | 組換えベクター |
| JP2019086133A Pending JP2019141088A (ja) | 2008-09-26 | 2019-04-26 | 組換えベクター |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011529291A Expired - Fee Related JP5771147B2 (ja) | 2008-09-26 | 2009-09-26 | 遺伝子治療ベクターおよびシトシンデアミナーゼ |
Family Applications After (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015004923A Expired - Fee Related JP5992548B2 (ja) | 2008-09-26 | 2015-01-14 | 組換えベクター |
| JP2015097980A Expired - Fee Related JP6062485B2 (ja) | 2008-09-26 | 2015-05-13 | 遺伝子治療ベクターおよびシトシンデアミナーゼ |
| JP2016159893A Expired - Fee Related JP6523224B2 (ja) | 2008-09-26 | 2016-08-17 | 組換えベクター |
| JP2019086133A Pending JP2019141088A (ja) | 2008-09-26 | 2019-04-26 | 組換えベクター |
Country Status (18)
| Country | Link |
|---|---|
| US (3) | US8722867B2 (enExample) |
| EP (4) | EP3460061A1 (enExample) |
| JP (6) | JP5771147B2 (enExample) |
| KR (3) | KR101724162B1 (enExample) |
| CN (4) | CN105624193B (enExample) |
| AU (1) | AU2009303690B2 (enExample) |
| BR (1) | BRPI0919113A2 (enExample) |
| CA (1) | CA2738472A1 (enExample) |
| CO (1) | CO6362050A2 (enExample) |
| DK (1) | DK2346995T3 (enExample) |
| EA (2) | EA027693B1 (enExample) |
| ES (2) | ES2706899T3 (enExample) |
| IL (3) | IL211847A (enExample) |
| MX (3) | MX357418B (enExample) |
| MY (1) | MY156333A (enExample) |
| NZ (1) | NZ592070A (enExample) |
| WO (2) | WO2010045002A2 (enExample) |
| ZA (1) | ZA201102115B (enExample) |
Families Citing this family (79)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69940521D1 (de) | 1998-10-01 | 2009-04-16 | Univ Southern California | Retrovirales genübertragungssystem und entsprechendes verwendungverfahren |
| US9320738B2 (en) | 2008-06-30 | 2016-04-26 | Tocagen Inc. | Formulations of 5-fluorocytosine and uses thereof |
| US8829173B2 (en) * | 2008-09-26 | 2014-09-09 | Tocagen Inc. | Recombinant vectors |
| CN105624193B (zh) | 2008-09-26 | 2021-07-13 | 索元生物医药(美国)有限公司 | 重组载体 |
| CA2764107A1 (en) * | 2009-06-17 | 2010-12-23 | Tocagen Inc. | Producer cells for replication competent retroviral vectors |
| WO2011156273A1 (en) * | 2010-06-06 | 2011-12-15 | Mount Sinai School Of Medicine | Recombinant rna viruses and uses thereof |
| WO2012009711A2 (en) | 2010-07-16 | 2012-01-19 | Tocagen Inc. | Retrovirus detection |
| WO2012058637A2 (en) | 2010-10-31 | 2012-05-03 | Tocagen Inc. | Antisera assays for mlv related viruses in humans and other mammals |
| US9669049B2 (en) | 2010-10-31 | 2017-06-06 | Tocagen Inc. | Compositions comprising gamma retrovirus vectors and methods of treating proliferative disorders |
| TWI486446B (zh) * | 2011-06-02 | 2015-06-01 | Taipei Veterans General Hospital | 治療感染性與惡性疾病的標靶化學治療藥物的形成方法 |
| KR101554678B1 (ko) * | 2012-10-19 | 2015-09-21 | 영남대학교 산학협력단 | 식물 바이러스를 이용한 식물체 형질전환을 위한 유전자 전달 시스템 및 이의 용도 |
| US11065311B2 (en) | 2012-10-25 | 2021-07-20 | Denovo Biopharma Llc | Retroviral vector with mini-promoter cassette |
| US20140161767A1 (en) * | 2012-11-15 | 2014-06-12 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Follicle-stimulating hormone (fsh)/lytic domain fusion constructs and methods of making and using same |
| US9642921B2 (en) | 2012-12-20 | 2017-05-09 | Tocagen Inc. | Cancer combination therapy and recombinant vectors |
| JP6640717B2 (ja) | 2013-06-15 | 2020-02-05 | トカジェン インコーポレーテッド | レトロウイルス複製ベクターと関連する免疫抑制成分 |
| CA2920049A1 (en) * | 2013-08-05 | 2015-02-12 | Tocagen Inc. | Recombinant vector with optimized a-bulge |
| CN103966260A (zh) * | 2014-03-07 | 2014-08-06 | 山东农业大学 | 一种基于J亚群禽白血病病毒pol基因保守序列的siRNA重组干扰载体及其制备方法和应用 |
| JP6894236B2 (ja) * | 2014-03-26 | 2021-06-30 | デノボ バイオファーマ エルエルシー | 免疫刺激活性を有するレトロウイルスベクター |
| AU2015243849B2 (en) | 2014-04-10 | 2020-12-17 | Seattle Children's Hospital (dba Seattle Children's Research Institute) | Transgene genetic tags and methods of use |
| WO2015168102A2 (en) * | 2014-04-28 | 2015-11-05 | Board Of Regents, The University Of Texas System | Prolonged protein stabilization by resveratrol |
| CN104557602B (zh) * | 2015-01-07 | 2016-08-17 | 华东师范大学 | 三环二萜衍生物及其制备方法、及其在制备抗肿瘤药物中的应用 |
| JP7162530B2 (ja) | 2015-08-07 | 2022-10-28 | シアトル チルドレンズ ホスピタル （ディービーエイ シアトル チルドレンズ リサーチ インスティテュート） | 固形腫瘍を標的とする二重特異性ｃａｒ ｔ細胞 |
| MX2018002744A (es) | 2015-09-04 | 2018-04-13 | Tocagen Inc | Vectores recombinantes que comprenden peptido 2a. |
| US11293021B1 (en) | 2016-06-23 | 2022-04-05 | Inscripta, Inc. | Automated cell processing methods, modules, instruments, and systems |
| GB2572716B (en) | 2016-11-29 | 2022-06-22 | Articure Co Ltd | Gene Therapy Vector System and Prodrug Genes |
| CN107058314B (zh) * | 2016-11-30 | 2020-09-04 | 暨南大学 | 一种启动子及其应用 |
| US11408005B2 (en) | 2016-12-12 | 2022-08-09 | Seattle Children's Hospital | Chimeric transcription factor variants with augmented sensitivity to drug ligand induction of transgene expression in mammalian cells |
| US10011849B1 (en) | 2017-06-23 | 2018-07-03 | Inscripta, Inc. | Nucleic acid-guided nucleases |
| US9982279B1 (en) | 2017-06-23 | 2018-05-29 | Inscripta, Inc. | Nucleic acid-guided nucleases |
| HUE058668T2 (hu) | 2017-06-30 | 2022-09-28 | Inscripta Inc | Automatizált sejtkezelési eljárások, modulok, berendezések és rendszerek |
| GB201710973D0 (en) | 2017-07-07 | 2017-08-23 | Avacta Life Sciences Ltd | Scaffold proteins |
| KR20200036873A (ko) * | 2017-07-14 | 2020-04-07 | 온코루스, 인크. | 캡슐화된 폴리뉴클레오티드 및 사용 방법 |
| WO2019133750A1 (en) | 2017-12-27 | 2019-07-04 | Ethicon Llc | Fluorescence imaging in a light deficient environment |
| TW202000238A (zh) * | 2018-02-26 | 2020-01-01 | 比利時商艾伯林克斯公司 | 編碼肽連接子之經改良核苷酸序列 |
| US10858761B2 (en) | 2018-04-24 | 2020-12-08 | Inscripta, Inc. | Nucleic acid-guided editing of exogenous polynucleotides in heterologous cells |
| US10526598B2 (en) | 2018-04-24 | 2020-01-07 | Inscripta, Inc. | Methods for identifying T-cell receptor antigens |
| CN110396504A (zh) * | 2018-04-25 | 2019-11-01 | 江苏省原子医学研究所 | 一种具有肿瘤靶向性的重组痘苗病毒及其制备方法、用途 |
| AU2019292919A1 (en) | 2018-06-30 | 2021-03-11 | Inscripta, Inc. | Instruments, modules, and methods for improved detection of edited sequences in live cells |
| US11142740B2 (en) | 2018-08-14 | 2021-10-12 | Inscripta, Inc. | Detection of nuclease edited sequences in automated modules and instruments |
| US11214781B2 (en) | 2018-10-22 | 2022-01-04 | Inscripta, Inc. | Engineered enzyme |
| EP3653716A1 (en) * | 2018-11-19 | 2020-05-20 | HSF Pharmaceuticals | Replication-competent controlled alpha-herpesvirus virus vectors and uses therefore |
| CN113631713A (zh) | 2019-03-25 | 2021-11-09 | 因思科瑞普特公司 | 酵母中的同时多重基因组编辑 |
| US11001831B2 (en) | 2019-03-25 | 2021-05-11 | Inscripta, Inc. | Simultaneous multiplex genome editing in yeast |
| US10837021B1 (en) | 2019-06-06 | 2020-11-17 | Inscripta, Inc. | Curing for recursive nucleic acid-guided cell editing |
| US11589819B2 (en) | 2019-06-20 | 2023-02-28 | Cilag Gmbh International | Offset illumination of a scene using multiple emitters in a laser mapping imaging system |
| US11096565B2 (en) | 2019-06-20 | 2021-08-24 | Cilag Gmbh International | Driving light emissions according to a jitter specification in a hyperspectral, fluorescence, and laser mapping imaging system |
| US11389066B2 (en) | 2019-06-20 | 2022-07-19 | Cilag Gmbh International | Noise aware edge enhancement in a pulsed hyperspectral, fluorescence, and laser mapping imaging system |
| US11280737B2 (en) | 2019-06-20 | 2022-03-22 | Cilag Gmbh International | Super resolution and color motion artifact correction in a pulsed fluorescence imaging system |
| US12126887B2 (en) | 2019-06-20 | 2024-10-22 | Cilag Gmbh International | Hyperspectral and fluorescence imaging with topology laser scanning in a light deficient environment |
| US11284783B2 (en) | 2019-06-20 | 2022-03-29 | Cilag Gmbh International | Controlling integral energy of a laser pulse in a hyperspectral imaging system |
| US10952619B2 (en) | 2019-06-20 | 2021-03-23 | Ethicon Llc | Hyperspectral and fluorescence imaging and topology laser mapping with minimal area monolithic image sensor |
| US12013496B2 (en) | 2019-06-20 | 2024-06-18 | Cilag Gmbh International | Noise aware edge enhancement in a pulsed laser mapping imaging system |
| US11012599B2 (en) | 2019-06-20 | 2021-05-18 | Ethicon Llc | Hyperspectral imaging in a light deficient environment |
| US11516387B2 (en) | 2019-06-20 | 2022-11-29 | Cilag Gmbh International | Image synchronization without input clock and data transmission clock in a pulsed hyperspectral, fluorescence, and laser mapping imaging system |
| US12181412B2 (en) | 2019-06-20 | 2024-12-31 | Cilag Gmbh International | Minimizing image sensor input/output in a pulsed hyperspectral, fluorescence, and laser mapping imaging system |
| US11712155B2 (en) | 2019-06-20 | 2023-08-01 | Cilag GmbH Intenational | Fluorescence videostroboscopy of vocal cords |
| US11237270B2 (en) | 2019-06-20 | 2022-02-01 | Cilag Gmbh International | Hyperspectral, fluorescence, and laser mapping imaging with fixed pattern noise cancellation |
| US12440085B2 (en) | 2019-06-20 | 2025-10-14 | Cilag Gmbh International | Image synchronization without input clock and data transmission clock in a pulsed laser mapping imaging system |
| US11617541B2 (en) | 2019-06-20 | 2023-04-04 | Cilag Gmbh International | Optical fiber waveguide in an endoscopic system for fluorescence imaging |
| JP7765379B2 (ja) | 2019-08-12 | 2025-11-06 | ピュリノミア バイオテック， インコーポレイテッド | Ｃｄ３９発現細胞のａｄｃｃ標的化を介してｔ細胞媒介性免疫応答を促進及び増強するための方法及び組成物 |
| KR102281858B1 (ko) * | 2019-09-11 | 2021-07-26 | 주식회사 쎌바이오텍 | 유산균 유래 p8 단백질의 발현 컨스트럭트를 포함하는 대장 질환의 치료 또는 예방용 조성물 |
| TW202128775A (zh) | 2019-10-16 | 2021-08-01 | 英商阿法克塔生命科學有限公司 | PD-L1抑制劑-TGFβ抑制劑雙特異性藥物部分 |
| WO2021102059A1 (en) | 2019-11-19 | 2021-05-27 | Inscripta, Inc. | Methods for increasing observed editing in bacteria |
| CA3157127A1 (en) | 2019-12-18 | 2021-06-24 | Aamir MIR | Cascade/dcas3 complementation assays for in vivo detection of nucleic acid-guided nuclease edited cells |
| KR20220133257A (ko) | 2020-01-27 | 2022-10-04 | 인스크립타 인코포레이티드 | 전기천공 모듈 및 기구 |
| US20210332388A1 (en) | 2020-04-24 | 2021-10-28 | Inscripta, Inc. | Compositions, methods, modules and instruments for automated nucleic acid-guided nuclease editing in mammalian cells |
| GB202101299D0 (en) | 2020-06-09 | 2021-03-17 | Avacta Life Sciences Ltd | Diagnostic polypetides and methods |
| CN111944810B (zh) * | 2020-07-29 | 2022-05-27 | 中国农业大学 | 靶向敲除TNFα基因的sgRNA和敲除TNFα基因的猪胚胎成纤维细胞系及其应用 |
| WO2022060749A1 (en) | 2020-09-15 | 2022-03-24 | Inscripta, Inc. | Crispr editing to embed nucleic acid landing pads into genomes of live cells |
| US11512297B2 (en) | 2020-11-09 | 2022-11-29 | Inscripta, Inc. | Affinity tag for recombination protein recruitment |
| CA3204158A1 (en) | 2021-01-04 | 2022-07-07 | Juhan Kim | Mad nucleases |
| US11332742B1 (en) | 2021-01-07 | 2022-05-17 | Inscripta, Inc. | Mad nucleases |
| US11884924B2 (en) | 2021-02-16 | 2024-01-30 | Inscripta, Inc. | Dual strand nucleic acid-guided nickase editing |
| WO2022234003A1 (en) | 2021-05-07 | 2022-11-10 | Avacta Life Sciences Limited | Cd33 binding polypeptides with stefin a protein |
| EP4412711A1 (en) | 2021-10-07 | 2024-08-14 | Avacta Life Sciences Limited | Serum half-life extended pd-l1 binding polypeptides |
| TW202334196A (zh) | 2021-10-07 | 2023-09-01 | 英商阿法克塔生命科學有限公司 | Pd-l1結合多肽 |
| LT7046B (lt) | 2022-04-15 | 2024-02-12 | Vilniaus Universitetas | Hidrolazės ir jų panaudojimas |
| WO2023212483A1 (en) | 2022-04-29 | 2023-11-02 | Purinomia Biotech, Inc. | Methods and compositions for treating eosinophil driven diseases and disorders |
| CN118697758B (zh) * | 2024-05-31 | 2025-10-21 | 河北大学 | miR-128-1-5p的应用 |
Family Cites Families (103)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4405712A (en) | 1981-07-01 | 1983-09-20 | The United States Of America As Represented By The Department Of Health And Human Services | LTR-Vectors |
| US4650764A (en) | 1983-04-12 | 1987-03-17 | Wisconsin Alumni Research Foundation | Helper cell |
| US4751180A (en) | 1985-03-28 | 1988-06-14 | Chiron Corporation | Expression using fused genes providing for protein product |
| US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
| US4935233A (en) | 1985-12-02 | 1990-06-19 | G. D. Searle And Company | Covalently linked polypeptide cell modulators |
| CA2018273C (en) | 1989-06-09 | 1999-04-06 | Peter D. Senter | Thermally stable cytosine deaminase |
| US5358866A (en) | 1991-07-03 | 1994-10-25 | The United States Of America As Represented By The Department Of Health And Human Services | Cytosine deaminase negative selection system for gene transfer techniques and therapies |
| US5770428A (en) * | 1993-02-17 | 1998-06-23 | Wisconsin Alumni Research Foundation | Chimeric retrovial expression vectors and particles containing a simple retroviral long terminal repeat, BLV or HIV coding regions and cis-acting regulatory sequences, and an RNA translational enhancer with internal ribsome entry site |
| DE69420033T2 (de) | 1993-04-06 | 1999-12-23 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Bethesda | Gibbon leukemia virus retrovirale vektoren |
| US5426039A (en) | 1993-09-08 | 1995-06-20 | Bio-Rad Laboratories, Inc. | Direct molecular cloning of primer extended DNA containing an alkane diol |
| CA2158935A1 (en) | 1993-10-12 | 1995-04-20 | Chiron Viagene, Inc. | Methods for preserving recombinant viruses |
| US5837458A (en) | 1994-02-17 | 1998-11-17 | Maxygen, Inc. | Methods and compositions for cellular and metabolic engineering |
| US5605793A (en) | 1994-02-17 | 1997-02-25 | Affymax Technologies N.V. | Methods for in vitro recombination |
| US6335160B1 (en) | 1995-02-17 | 2002-01-01 | Maxygen, Inc. | Methods and compositions for polypeptide engineering |
| US6117679A (en) | 1994-02-17 | 2000-09-12 | Maxygen, Inc. | Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
| US5834252A (en) | 1995-04-18 | 1998-11-10 | Glaxo Group Limited | End-complementary polymerase reaction |
| WO1996014328A1 (en) | 1994-11-07 | 1996-05-17 | Human Genome Sciences, Inc. | Tumor necrosis factor-gamma |
| US20030157070A1 (en) | 1994-12-30 | 2003-08-21 | Jolly Douglas J. | High efficiency ex vivo transduction of cells by high titer recombinant retroviral preparations |
| US6117681A (en) | 1995-03-29 | 2000-09-12 | Bavarian Nordic Research Inst. A/S | Pseudotyped retroviral particles |
| JPH11507205A (ja) | 1995-04-27 | 1999-06-29 | ヒューマン・ジェノム・サイエンシズ・インコーポレイテッド | ヒト腫瘍壊死因子受容体 |
| US20030026789A1 (en) | 1995-05-03 | 2003-02-06 | Richard J. Gregory | Gene therapy using replication competent targeted adenoviral vectors |
| WO1997033904A1 (en) | 1996-03-12 | 1997-09-18 | Human Genome Sciences, Inc. | Death domain containing receptors |
| WO1997033899A1 (en) | 1996-03-14 | 1997-09-18 | Human Genome Sciences, Inc. | Apoptosis inducing molecule i |
| US6096548A (en) | 1996-03-25 | 2000-08-01 | Maxygen, Inc. | Method for directing evolution of a virus |
| DE69738749D1 (de) | 1996-08-16 | 2008-07-17 | Schering Corp | Zelloberflächen-antigen aus säugetieren und verwandte reagenzien |
| CA2264200A1 (en) | 1996-08-16 | 1998-02-26 | Human Genome Sciences, Inc. | Human endokine alpha |
| AU4503797A (en) | 1996-09-27 | 1998-04-17 | Maxygen, Inc. | Methods for optimization of gene therapy by recursive sequence shuffling and selection |
| DK0939804T4 (da) | 1996-10-25 | 2011-07-18 | Human Genome Sciences Inc | Neutrokin-alpha |
| WO1998030693A2 (en) | 1997-01-14 | 1998-07-16 | Human Genome Sciences, Inc. | Tumor necrosis factor receptor 5 |
| US6326204B1 (en) | 1997-01-17 | 2001-12-04 | Maxygen, Inc. | Evolution of whole cells and organisms by recursive sequence recombination |
| AU743305C (en) | 1997-01-17 | 2006-03-30 | Maxygen, Inc. | Evolution of whole cells and organisms by recursive sequence recombination |
| EP1012274B2 (en) | 1997-01-28 | 2011-06-15 | Human Genome Sciences, Inc. | Death domain containing receptor 4 (dr4: death receptor 4), member of the tnf-receptor superfamily and binding to trail (ap0-2l) |
| DK0996718T3 (da) | 1997-03-18 | 2009-04-06 | Novozymes As | Fremgangsmåde til konstruktion af et bibliotek ved anvendelse af DNA-shuffling |
| BR9808368A (pt) | 1997-03-18 | 2000-05-23 | Novo Nordisk As | Processos para a construção de uma biblioteca de polinucleotideos homólogos recombinados, para a identificação um polipeptìdeo de interesse, e, para a produção de um polipeptìdeo de interesse. |
| US5948653A (en) | 1997-03-21 | 1999-09-07 | Pati; Sushma | Sequence alterations using homologous recombination |
| US6153410A (en) | 1997-03-25 | 2000-11-28 | California Institute Of Technology | Recombination of polynucleotide sequences using random or defined primers |
| AU7705198A (en) | 1997-05-30 | 1998-12-30 | Human Genome Sciences, Inc. | Human tumor necrosis factor receptor tr10 |
| AU7830398A (en) | 1997-06-11 | 1998-12-30 | Human Genome Sciences, Inc. | Human tumor necrosis factor receptor tr9 |
| EP1025208A2 (en) | 1997-10-20 | 2000-08-09 | Universita' Degli Studi Di Padova | A packaging cell line producing siv-pseudotyped mlv |
| AU1124499A (en) | 1997-10-28 | 1999-05-17 | Maxygen, Inc. | Human papillomavirus vectors |
| EP1030861A4 (en) | 1997-10-31 | 2001-09-05 | Maxygen Inc | MODIFICATION OF VIRUSTROPISMIUS AND THE ECONOMIC SPECTRUM BY VIRAL GENOM MIXING |
| AU746786B2 (en) | 1997-12-08 | 2002-05-02 | California Institute Of Technology | Method for creating polynucleotide and polypeptide sequences |
| FR2773561A1 (fr) | 1998-01-15 | 1999-07-16 | Centre Nat Rech Scient | Utilisation d'une sequence riche en proline pour augmenter le caractere fusogenique d'enveloppes de retrovirus |
| CA2320960A1 (en) | 1998-02-11 | 1999-08-19 | Maxygen, Inc. | Optimization of immunomodulatory properties of genetic vaccines |
| WO1999041383A1 (en) | 1998-02-11 | 1999-08-19 | Maxygen, Inc. | Antigen library immunization |
| US6451304B1 (en) | 1998-03-09 | 2002-09-17 | The Regents Of The University Of California | Method for retrovirus vector production by separated gag and pol expression |
| JP2002512805A (ja) | 1998-04-29 | 2002-05-08 | オクラホマ メディカル リサーチ ファウンデーション | アデノウイルスベクターおよびレトロウイルスベクターからのレトロウイルスプロデューサー細胞の構築 |
| US7001733B1 (en) | 1998-05-12 | 2006-02-21 | Rigel Pharmaceuticals, Inc. | Methods and compositions for screening for modulations of IgE synthesis, secretion and switch rearrangement |
| GB9810752D0 (en) | 1998-05-19 | 1998-07-15 | Glaxo Group Ltd | Cystosine deaminase gene |
| US6448390B1 (en) | 1998-05-20 | 2002-09-10 | The University Of Tennessee Research Corporation | Stable envelope proteins for retroviral, viral and liposome vectors and use in gene drug therapy |
| ES2381824T3 (es) | 1998-06-29 | 2012-05-31 | Bristol-Myers Squibb Company | Procedimientos para generar genotecas muy diversas |
| US6264940B1 (en) | 1998-08-05 | 2001-07-24 | The Research Foundation Of State University Of New York | Recombinant poliovirus for the treatment of cancer |
| FR2782323B1 (fr) | 1998-08-12 | 2002-01-11 | Proteus | Procede de production in vitro de sequences polynucleotidiques recombinees, banques de sequences et sequences ainsi obtenues |
| IL140441A0 (en) | 1998-09-29 | 2002-02-10 | Maxygen Inc | Shuffling of codon altered genes |
| US6899871B2 (en) * | 1998-10-01 | 2005-05-31 | University Of Southern California | Gene delivery system and methods of use |
| DE69940521D1 (de) | 1998-10-01 | 2009-04-16 | Univ Southern California | Retrovirales genübertragungssystem und entsprechendes verwendungverfahren |
| US6576463B1 (en) | 1999-01-15 | 2003-06-10 | The Regents Of The University Of California | Hybrid vectors for gene therapy |
| WO2000042559A1 (en) | 1999-01-18 | 2000-07-20 | Maxygen, Inc. | Methods of populating data structures for use in evolutionary simulations |
| WO2000042560A2 (en) | 1999-01-19 | 2000-07-20 | Maxygen, Inc. | Methods for making character strings, polynucleotides and polypeptides |
| US6436675B1 (en) | 1999-09-28 | 2002-08-20 | Maxygen, Inc. | Use of codon-varied oligonucleotide synthesis for synthetic shuffling |
| CA2371946A1 (en) | 1999-04-29 | 2000-11-09 | Aarhus University | Expression of heterologous genes from an ires translational cassette in retroviral vectors |
| AU6085500A (en) | 1999-07-08 | 2001-01-30 | Regents Of The University Of California, The | A lung cancer associated retrovirus, gene delivery vector and methods of use thereof |
| WO2001040488A1 (en) | 1999-11-30 | 2001-06-07 | Novartis Ag | Increased transgene expression in retroviral vectors having scaffold attachment region |
| EP1261376A1 (en) | 2000-01-27 | 2002-12-04 | Genetics Institute, LLC | Antibodies against ctla4(cd152), conjugates comprising same, and uses thereof |
| AU2001241939A1 (en) | 2000-02-28 | 2001-09-12 | Maxygen, Inc. | Single-stranded nucleic acid template-mediated recombination and nucleic acid fragment isolation |
| US6692736B2 (en) | 2000-03-24 | 2004-02-17 | Cell Genesys, Inc. | Cell-specific adenovirus vectors comprising an internal ribosome entry site |
| AU2001292711A1 (en) | 2000-09-18 | 2002-03-26 | Genetic Therapy, Inc. | Stress resistant retroviruses |
| WO2002042482A2 (en) * | 2000-11-27 | 2002-05-30 | Chiron Corporation | Functional lentiviral vector from an mlv-based backbone |
| US7226779B2 (en) | 2001-01-30 | 2007-06-05 | The United States Of America As Represented By The Department Of Health And Human Services | Hybrid adenoviral vector |
| DE10111433A1 (de) | 2001-03-09 | 2002-09-19 | Bundesrepublik Deutschland Let | Replikationskompetente molekulare Klone von porcinem endogenem Retrovirus der Klasse A und Klasse B,abgeleitet von Schweine- und humanen Zellen |
| JP2002335965A (ja) | 2001-05-14 | 2002-11-26 | Japan Science & Technology Corp | 細胞特異的発現複製ベクター |
| DE10143237A1 (de) | 2001-09-04 | 2003-03-20 | Icon Genetics Ag | Herstellung künstlicher interner ribosomaler Eingangsstellenelemente (Ires-Elemente) |
| AU2002326906C1 (en) * | 2001-09-13 | 2009-01-29 | California Institute Of Technology | Method for expression of small antiviral RNA molecules within a cell |
| FR2832424B1 (fr) | 2001-11-20 | 2004-09-24 | Genethon Iii | Plasmide chimere comprenant un genome retroviral replicatif et utilisations |
| US20030121068A1 (en) * | 2001-11-30 | 2003-06-26 | Paul Orchard | Vector encoding suicide and marker constructs |
| EP1470233A1 (en) | 2002-02-01 | 2004-10-27 | Transgene S.A. | Adenoviral vectors for modulating the cellular activities associated with pods |
| AU2003251931B2 (en) | 2002-07-17 | 2008-03-06 | Bristol-Myers Squibb Company | Transgenic non-human mammals expressing a reporter nucleic acid under the regulation of androgen response elements |
| WO2004022761A1 (en) * | 2002-09-03 | 2004-03-18 | Oxford Biomedica (Uk) Limited | Retroviral vector and stable packaging cell lines |
| DE602004031341D1 (de) * | 2003-07-21 | 2011-03-24 | Transgene Sa | Multifunktionelle cytokine |
| CN1826410B (zh) * | 2003-07-21 | 2011-10-26 | 特兰斯吉恩股份有限公司 | 具有改良的胞嘧啶脱氨酶活性的多肽 |
| WO2005086922A2 (en) * | 2004-03-10 | 2005-09-22 | Board Of Regents, University Of Texas System | Oncolytic adenovirus armed with therapeutic genes |
| US20080227736A1 (en) | 2004-06-03 | 2008-09-18 | Regents Of The University Of California, | Targeting Pseudotyped Retroviral Vectors |
| US20070003522A1 (en) | 2004-07-08 | 2007-01-04 | Albritton Lorraine M | Methods and compositions for improved retroviral gene and drug delivery |
| CA2586844A1 (en) | 2004-11-04 | 2006-05-11 | Pfizer Products Inc. | Ctla-4 antibody and aromatase inhibitor or combination treatment for breast cancer |
| WO2006058231A2 (en) * | 2004-11-24 | 2006-06-01 | Nanovector Limited | Viral vectors |
| US20060147429A1 (en) * | 2004-12-30 | 2006-07-06 | Paul Diamond | Facilitated cellular reconstitution of organs and tissues |
| WO2006127980A2 (en) | 2005-05-25 | 2006-11-30 | The Regents Of The University Of California | Optimized core promoters and uses therefor |
| JP2007054069A (ja) * | 2005-08-24 | 2007-03-08 | Medizinische Hochschule Hannover | 自己不活性化レトロウイルスベクター |
| AU2006296840A1 (en) * | 2005-09-30 | 2007-04-05 | Zgene A/S | Dekkera/Brettanomyces cytosine deaminases and their use |
| EP2386564B1 (en) * | 2005-10-01 | 2014-07-16 | Charles Stout | Regulatable fusion promoters |
| US8034355B2 (en) | 2005-10-07 | 2011-10-11 | Presidents And Fellows Of Harvard College | Attenuated nonsegmented negative-sense RNA viruses with reduced mRNA cap methyltransferase activity comprising mutations within conserved domain VI of the large polymerase |
| EP1795596A1 (en) * | 2005-12-08 | 2007-06-13 | Ganymed Pharmaceuticals AG | Composition and methods for therapy and diagnosis of cancer |
| EP2484782B1 (en) * | 2006-01-05 | 2015-11-18 | The Ohio State University Research Foundation | MicroRNA-based methods and compositions for the diagnosis and treatment of solid cancers |
| WO2007095201A2 (en) | 2006-02-15 | 2007-08-23 | The Regents Of The University Of California | Pseudotyped retroviral vectors and methods of use thereof |
| EP2004677A2 (en) | 2006-03-17 | 2008-12-24 | Aarhus Universitet | Chimeric viral envelopes |
| US9868961B2 (en) * | 2006-03-30 | 2018-01-16 | The Regents Of The University Of California | Methods and compositions for localized secretion of anti-CTLA-4 antibodies |
| BRPI0714495B8 (pt) * | 2006-07-21 | 2021-05-25 | California Inst Of Techn | lentivírus deficiente para replicação recombinante pseudotipado |
| WO2008151633A2 (en) | 2007-06-15 | 2008-12-18 | Skau Aps | Vectors for vaccines against lentivirus infections |
| US9320738B2 (en) * | 2008-06-30 | 2016-04-26 | Tocagen Inc. | Formulations of 5-fluorocytosine and uses thereof |
| US8829173B2 (en) * | 2008-09-26 | 2014-09-09 | Tocagen Inc. | Recombinant vectors |
| CN105624193B (zh) * | 2008-09-26 | 2021-07-13 | 索元生物医药(美国)有限公司 | 重组载体 |
| CA2764107A1 (en) * | 2009-06-17 | 2010-12-23 | Tocagen Inc. | Producer cells for replication competent retroviral vectors |
| CA2805937A1 (en) | 2010-08-13 | 2012-02-16 | Pioneer Hi-Bred International, Inc. | Chimeric promoters and methods of use |
-
2009
- 2009-09-26 CN CN201510624987.9A patent/CN105624193B/zh not_active Expired - Fee Related
- 2009-09-26 DK DK09820986.9T patent/DK2346995T3/en active
- 2009-09-26 CN CN200980147515.1A patent/CN102227503B/zh not_active Expired - Fee Related
- 2009-09-26 EA EA201170492A patent/EA027693B1/ru not_active IP Right Cessation
- 2009-09-26 CN CN201510505943.4A patent/CN105274125A/zh active Pending
- 2009-09-26 JP JP2011529291A patent/JP5771147B2/ja not_active Expired - Fee Related
- 2009-09-26 ES ES09820986T patent/ES2706899T3/es active Active
- 2009-09-26 KR KR1020117008744A patent/KR101724162B1/ko not_active Expired - Fee Related
- 2009-09-26 EA EA201790824A patent/EA201790824A3/ru unknown
- 2009-09-26 MX MX2015010159A patent/MX357418B/es unknown
- 2009-09-26 AU AU2009303690A patent/AU2009303690B2/en not_active Ceased
- 2009-09-26 EP EP18188075.8A patent/EP3460061A1/en not_active Withdrawn
- 2009-09-26 CA CA2738472A patent/CA2738472A1/en not_active Abandoned
- 2009-09-26 EP EP09820986.9A patent/EP2346995B1/en active Active
- 2009-09-26 WO PCT/US2009/058510 patent/WO2010045002A2/en not_active Ceased
- 2009-09-26 JP JP2011529292A patent/JP5684130B2/ja not_active Expired - Fee Related
- 2009-09-26 CN CN200980147509.6A patent/CN102227501B/zh not_active Expired - Fee Related
- 2009-09-26 MX MX2011003039A patent/MX2011003039A/es active IP Right Grant
- 2009-09-26 WO PCT/US2009/058512 patent/WO2010036986A2/en not_active Ceased
- 2009-09-26 EP EP09816967.5A patent/EP2344648B1/en active Active
- 2009-09-26 NZ NZ592070A patent/NZ592070A/en not_active IP Right Cessation
- 2009-09-26 MY MYPI2011001328A patent/MY156333A/en unknown
- 2009-09-26 BR BRPI0919113A patent/BRPI0919113A2/pt not_active IP Right Cessation
- 2009-09-26 KR KR1020187016894A patent/KR102025502B1/ko not_active Expired - Fee Related
- 2009-09-26 EP EP18198570.6A patent/EP3502256A3/en not_active Withdrawn
- 2009-09-26 ES ES09816967T patent/ES2709481T3/es active Active
- 2009-09-26 KR KR1020167016947A patent/KR101870056B1/ko not_active Expired - Fee Related
-
2011
- 2011-03-18 MX MX2018008440A patent/MX2018008440A/es unknown
- 2011-03-22 IL IL211847A patent/IL211847A/en active IP Right Grant
- 2011-03-22 ZA ZA2011/02115A patent/ZA201102115B/en unknown
- 2011-03-26 US US13/072,705 patent/US8722867B2/en active Active
- 2011-04-25 CO CO11050300A patent/CO6362050A2/es not_active Application Discontinuation
-
2014
- 2014-05-09 US US14/274,556 patent/US10035983B2/en active Active
-
2015
- 2015-01-14 JP JP2015004923A patent/JP5992548B2/ja not_active Expired - Fee Related
- 2015-05-13 JP JP2015097980A patent/JP6062485B2/ja not_active Expired - Fee Related
-
2016
- 2016-08-17 JP JP2016159893A patent/JP6523224B2/ja not_active Expired - Fee Related
- 2016-11-08 IL IL248833A patent/IL248833B/en active IP Right Grant
-
2018
- 2018-07-24 US US16/044,472 patent/US20190185821A1/en not_active Abandoned
-
2019
- 2019-01-13 IL IL264214A patent/IL264214B/en not_active IP Right Cessation
- 2019-04-26 JP JP2019086133A patent/JP2019141088A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20220195460A1 (en) | Retroviral vector having immune-stimulating activity | |
| JP6523224B2 (ja) | 組換えベクター | |
| EP0832980B1 (en) | Recombinant therapies for infection and hyperproliferative disorders | |
| US8829173B2 (en) | Recombinant vectors | |
| JP6419706B2 (ja) | ミニプロモーターカセットを含むレトロウイルスベクター | |
| JP2018526007A (ja) | ２ａペプチドを含む組換えベクター | |
| JPH10179181A (ja) | 感染および過剰増殖障害の為の組換え療法 | |
| CN105579581A (zh) | 具有优化的a凸出物的重组载体 | |
| JP4343708B2 (ja) | 改良型キメラ糖タンパク質と、類型化されたレンチウイルス | |
| CN116670172A (zh) | 表达免疫检查点抑制剂的癌症特异性反式剪接核酶及其用途 | |
| EP3784278B1 (en) | Foamy viruses and methods of use | |
| US20160222412A1 (en) | Recombinant vector with stabilizing a-loop | |
| CN120647771A (zh) | 一种激活免疫细胞杀伤肿瘤细胞的融合蛋白及其重组病毒和用途 | |
| JP2024526878A (ja) | 調節されたウイルス送達システムおよびその使用 | |
| Duarte | 77. HIV-1 Vector Production Mediated by Rev Protein Transduction | |
| Gentry | T Lymphocyte Based HIV Gene Therapy Strategies |